These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 566576)

  • 21. Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans.
    Koos RD; LeMaire WJ; Hung TT; Brodie AM
    Steroids; 1985 Feb; 45(2):143-50. PubMed ID: 4089916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy can be established in superovulated adult rats treated with progesterone and an aromatase inhibitor.
    Hayes RA; Miller K; Akira S; Lin YC; Friedman CI; Kim MH
    Life Sci; 1993; 52(1):61-71. PubMed ID: 8417279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the hydrophobic pocket of the active site of aromatase with 4-phenoxy-7 alpha-(phenylthio)-4-androstene-3,17-dione.
    Liu XP; Lambert DM; Abul-Hajj YJ
    J Med Chem; 1995 Sep; 38(20):4135-8. PubMed ID: 7562951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of recent development of aromatase inhibitors.
    Brodie AM
    Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of deuterium- and tritium-labelled 4-hydroxyandrostene-3,17-dione, an aromatase inhibitor, and its metabolism in vitro and in vivo in the rat.
    Marsh DA; Romanoff L; Williams KI; Brodie HJ; Brodie AM
    Biochem Pharmacol; 1982 Mar; 31(5):701-5. PubMed ID: 7082338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibition and its pharmacologic implications.
    Brodie AM
    Biochem Pharmacol; 1985 Sep; 34(18):3213-9. PubMed ID: 3899122
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of 17 beta-estradiol synthesis in the proestrous hamster: role of progesterone and luteinizing hormone.
    Saidapur SK; Greenwald GS
    Endocrinology; 1979 Dec; 105(6):1432-9. PubMed ID: 574076
    [No Abstract]   [Full Text] [Related]  

  • 31. Aromatase inhibitors and their use in controlling oestrogen-dependent processes.
    Brodie AM; Marsh DA; Wu JT; Brodie HJ
    J Steroid Biochem; 1979 Jul; 11(1A):107-12. PubMed ID: 114710
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aromatase inhibitors on the histology of the cycling rat ovary.
    Coney P; Yoshimura Y; Hosoi Y; Bongiovanni A; Wallach E
    Gynecol Obstet Invest; 1987; 23(3):177-83. PubMed ID: 3596353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of treatment with aromatase inhibitor 4-hydroxandrostenedione on the nonhuman primate menstrual cycle.
    Brodie AM; Hammond JO; Ghosh M; Meyer K; Albrecht ED
    Cancer Res; 1989 Sep; 49(17):4780-4. PubMed ID: 2758411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of ovarian steroid biosynthesis by estrogen during proestrus in the rat.
    Banks PK; Meyer K; Brodie AM
    Endocrinology; 1991 Sep; 129(3):1295-304. PubMed ID: 1874172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
    Johnston JO; Wright CL; Metcalf BW
    Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
    Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
    Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
    Habenicht UF; Schwarz K; Neumann F; el Etreby MF
    Prostate; 1987; 11(4):313-26. PubMed ID: 2446299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.